Compare Biocon Ltd with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs DIVIS LABORATORIES - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON DIVIS LABORATORIES BIOCON /
DIVIS LABORATORIES
 
P/E (TTM) x 30.7 41.7 73.6% View Chart
P/BV x 4.0 8.3 47.9% View Chart
Dividend Yield % 0.2 0.7 33.6%  

Financials

 BIOCON    DIVIS LABORATORIES
EQUITY SHARE DATA
    BIOCON
Mar-19
DIVIS LABORATORIES
Mar-19
BIOCON /
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs7071,639 43.1%   
Low Rs5541,115 49.7%   
Sales per share (Unadj.) Rs91.9186.3 49.3%  
Earnings per share (Unadj.) Rs16.751.0 32.8%  
Cash flow per share (Unadj.) Rs24.257.3 42.2%  
Dividends per share (Unadj.) Rs1.0016.00 6.3%  
Dividend yield (eoy) %0.21.2 13.7%  
Book value per share (Unadj.) Rs101.6261.8 38.8%  
Shares outstanding (eoy) m600.00265.47 226.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.97.4 92.8%   
Avg P/E ratio x37.727.0 139.6%  
P/CF ratio (eoy) x26.124.0 108.6%  
Price / Book Value ratio x6.25.3 117.9%  
Dividend payout %6.031.4 19.1%   
Avg Mkt Cap Rs m378,330365,592 103.5%   
No. of employees `0006.111.8 51.8%   
Total wages/salary Rs m11,6535,423 214.9%   
Avg. sales/employee Rs Th8,994.34,175.1 215.4%   
Avg. wages/employee Rs Th1,900.7457.7 415.2%   
Avg. net profit/employee Rs Th1,635.31,141.8 143.2%   
INCOME DATA
Net Sales Rs m55,14449,463 111.5%  
Other income Rs m1,4441,556 92.8%   
Total revenues Rs m56,58851,019 110.9%   
Gross profit Rs m15,88318,718 84.9%  
Depreciation Rs m4,4781,689 265.1%   
Interest Rs m70935 2,025.7%   
Profit before tax Rs m12,14018,551 65.4%   
Minority Interest Rs m90-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,1235,023 42.3%   
Profit after tax Rs m10,02613,527 74.1%  
Gross profit margin %28.837.8 76.1%  
Effective tax rate %17.527.1 64.6%   
Net profit margin %18.227.3 66.5%  
BALANCE SHEET DATA
Current assets Rs m48,22846,501 103.7%   
Current liabilities Rs m30,3768,468 358.7%   
Net working cap to sales %32.476.9 42.1%  
Current ratio x1.65.5 28.9%  
Inventory Days Days68131 52.2%  
Debtors Days Days8686 99.6%  
Net fixed assets Rs m64,13025,797 248.6%   
Share capital Rs m3,000531 565.1%   
"Free" reserves Rs m57,98068,962 84.1%   
Net worth Rs m60,98069,493 87.7%   
Long term debt Rs m15,7660-   
Total assets Rs m121,92480,383 151.7%  
Interest coverage x18.1531.0 3.4%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.50.6 73.5%   
Return on assets %8.816.9 52.2%  
Return on equity %16.419.5 84.5%  
Return on capital %16.826.7 62.6%  
Exports to sales %28.10-   
Imports to sales %18.924.6 76.5%   
Exports (fob) Rs m15,506NA-   
Imports (cif) Rs m10,39912,187 85.3%   
Fx inflow Rs m15,50641,238 37.6%   
Fx outflow Rs m10,39912,405 83.8%   
Net fx Rs m5,10728,833 17.7%   
CASH FLOW
From Operations Rs m11,5469,543 121.0%  
From Investments Rs m-7,138-6,854 104.1%  
From Financial Activity Rs m-2,417-2,459 98.3%  
Net Cashflow Rs m2,103230 915.9%  

Share Holding

Indian Promoters % 40.4 52.0 77.7%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 11.8 71.2%  
FIIs % 10.7 19.0 56.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 17.2 115.7%  
Shareholders   109,995 31,796 345.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  FDC LTD.  ABBOTT INDIA  PANACEA BIOTECH  

Compare BIOCON With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 466 Points Higher; Energy, Auto and Realty Stocks Rally(Closing)

Indian share markets extended gains as the session progressed and ended on a strong note, driven by automobile stocks and index heavyweight Reliance Industries.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (4QFY20); Net Profit Up 35.4% (Quarterly Result Update)

Jun 8, 2020 | Updated on Jun 8, 2020

For the quarter ended March 2020, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 35.4% YoY). Sales on the other hand came in at Rs 14 bn (up 9.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (3QFY20); Net Profit Down 4.9% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 4.9% YoY). Sales on the other hand came in at Rs 14 bn (up 3.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (2QFY20); Net Profit Down 10.3% (Quarterly Result Update)

Nov 11, 2019 | Updated on Nov 11, 2019

For the quarter ended September 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 10.3% YoY). Sales on the other hand came in at Rs 14 bn (up 12.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Jul 6, 2020 03:33 PM

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS